Quantcast
Channel: Clinical trial(s) – Pharmamarketeer
Viewing all articles
Browse latest Browse all 35

Breakthrough study could revolutionise MS treatment

$
0
0

The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from all quarters, given that it seems to show the repair of myelin damaged by multiple sclerosis (MS) and, to add to the news, is achieved through the use of a generic allergy medication.


Viewing all articles
Browse latest Browse all 35

Trending Articles